ANAB logo

AnaptysBio (ANAB)

Profile

Full Name

AnaptysBio, Inc.

Ticker Symbol

ANAB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

January 26, 2017

Indexes

Not included

Website

http://www.anaptysbio.com

Employees

136

Key Details

Price

$18.50(+2.24%)

Market cap

$567.49M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$91.28M(+432.03% YoY)

Annual EPS

-$5.12(+15.79% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$18.50
ANAB price is $18.50

30-Day Relative Volume

1.25
ANAB 30-day relative volume is 1.25

Price Performance

Price Today change

+2.24%
ANAB price is up +2.24% today

Price YTD change

+39.77%
ANAB price is up +39.77% since January 1st

Price 1-year change

-13.28%
ANAB price is down -13.28% year-on-year

Price 3-year change

-19.05%
ANAB price is down -19.05% over the past 3 years

Price Range

Price All-time high

$134.00
ANAB price is currently -86.19% below its historical high of $134.00

Price 3-year low

$12.21
ANAB price is currently +51.56% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$567.49M
ANAB market capitalization is $567.49 million

Market cap 3-year change

-11.92%
ANAB market capitalization is down -11.92% over the past 3 years

Market cap All-time high

$3.06B
ANAB market capitalization is currently -81.46% below its historical high of $3.06 billion

Market cap sector rank

70.97%
ANAB market capitalization is higher than 70.97% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+12.26%
ANAB shares outstanding is up +12.26% year-on-year

Shares Outstanding 3-Year Change

+8.81%
ANAB shares outstanding is up +8.81% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.74
ANAB beta is 0.74

200-day SMA

$24.79
ANAB price is currently -25.37% below its 200-day simple moving average

50-day SMA

$17.26
ANAB price is currently +7.20% above its 50-day simple moving average

RSI

53.22
ANAB 14-day relative strength index is 53.22

Volume

1.25
ANAB 30-day relative volume is 1.25

ATR

$1.43
ANAB average true range is $1.43

10-day Historical Volatility

60.51%
ANAB 10-day historical volatility is 60.51%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$91.28M
ANAB annual revenue is $91.28 million

Revenue Analysts estimate

$48.51M
ANAB annual revenue is currently +88.18% higher than the consensus analysts' forecast

Revenue 1-year change

+432.03%
ANAB annual revenue is up +432.03% year-on-year

Revenue Sector rank

55.53%
ANAB annual revenue is higher than 55.53% of companies in Healthcare sector

EPS

EPS

-$5.12
ANAB annual earnings per share is -$5.12

EPS Analysts estimate

-$5.30
ANAB annual earnings per share is currently -3.36% lower than the consensus analysts' forecast

EPS 1-year change

+15.79%
ANAB annual earnings per share is up +15.79% year-on-year

EPS Sector rank

18.81%
ANAB annual earnings per share is higher than 18.81% of companies in Healthcare sector

Profit

Gross profit

-
ANAB annual gross profit value is unknown

Gross margin

-
ANAB annual gross profit margin value is unknown

Operating profit

-$114.95M
ANAB annual operating income is -$114.95 million

Operating margin

-125.93%
ANAB annual operating profit margin is -125.93%

Net income

-$145.23M
ANAB annual net profit is -$145.23 million

Net margin

-159.11%
ANAB annual net profit margin is -159.11%

Expenses

Total expenses

$206.23M
ANAB annual total expenses is $206.23 million

Operating expenses

$206.23M
ANAB annual total operating expenses is $206.23 million

Cost of goods sold

-
ANAB annual cost of goods sold value is unknown

Selling, general & administrative expenses

$42.39M
ANAB annual SGA is $42.39 million

Depreciation and amortization

$2.40M
ANAB annual depreciation & amortization is $2.40 million

Interest expense

$50.09M
ANAB annual interest expense is $50.09 million

Income tax

$3000.00
ANAB annual income tax is $3000.00

EBIT & EBITDA

EBIT

-$95.14M
ANAB annual earnings before interest & taxes is -$95.14 million

EBITDA

-$92.74M
ANAB annual EBITDA is -$92.74 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$483.83M
ANAB annual total assets is $483.83 million

Non current assets

$51.96M
ANAB annual long term assets is $51.96 million

Current assets

$431.88M
ANAB annual total current assets is $431.88 million

Cash and cash equivalents

$123.08M
ANAB annual cash & cash equivalents is $123.08 million

Accounts receivable

$40.77M
ANAB annual accounts receivable is $40.77 million

Inventory

-
ANAB annual inventory value is unknown

Liabilities

Total liabilities

$412.97M
ANAB annual total liabilities is $412.97 million

Long term liabilities

$367.54M
ANAB annual total long term liabilities is $367.54 million

Current liabilities

$45.43M
ANAB annual total current liabilities is $45.43 million

Accounts payable

$4.00M
ANAB annual accounts payable is $4.00 million

Debt

Total debt

$16.04M
ANAB annual total debt is $16.04 million

Total debt 1-year change

-9.98%
ANAB annual total debt is down -9.98% year-on-year

Long term debt

$14.11M
ANAB annual long term debt is $14.11 million

Short term debt

$1.93M
ANAB annual short term debt is $1.93 million

Equity & Capital

Shareholders equity

$70.87M
ANAB annual stockholders equity is $70.87 million

Book value

$70.87M
ANAB annual book value is $70.87 million

Retained earnings

-$759.33M
ANAB annual retained earnings is -$759.33 million

Working capital

$386.45M
ANAB annual working capital is $386.45 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$135.34M
ANAB annual cash flow from operations is -$135.34 million

Cash from operations 1-year change

-12.03%
ANAB annual cash flow from operations is down -12.03% year-on-year

Cash from investing

$95.40M
ANAB annual cash flow from investing activities is $95.40 million

Cash from investing 1-year change

-34.1%
ANAB annual cash flow from investing activities is down -34.1% year-on-year

Cash from financing

$127.05M
ANAB annual cash flow from financing activities is $127.05 million

Cash from financing 1-year change

+314.27%
ANAB annual cash flow from financing activities is up +314.27% year-on-year

CAPEX

CAPEX

$358.00K
ANAB annual capital expenditures is $358.00 thousand

CAPEX 1-year change

-55.64%
ANAB annual capital expenditures is down -55.64% year-on-year

Free Cash Flow

Free cash flow

-$135.69M
ANAB annual free cash flow is -$135.69 million

Free cash flow 1-year change

-11.58%
ANAB annual free cash flow is down -11.58% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ANAB annual gross profit margin value is unknown

Operating margin

-125.93%
ANAB annual operating profit margin is -125.93%

Net margin

-159.11%
ANAB annual net profit margin is -159.11%

ROA & ROE

ROA

-31.02%
ANAB annual return on assets is -31.02%

ROE

-182.71%
ANAB annual return on equity is -182.71%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ANAB price to earnings ratio value is unknown

PE ratio Sector rank

-
ANAB price to earnings ratio is unknown

PB Ratio

PB ratio

8.01
ANAB price to book ratio is 8.01

PB ratio Sector rank

90.45%
ANAB price to book ratio is higher than 90.45% of companies in Healthcare sector

PS Ratio

PS ratio

6.22
ANAB price to sales ratio is 6.22

PS ratio Sector rank

70.9%
ANAB price to sales ratio is higher than 70.9% of companies in Healthcare sector

Enterprise value

Enterprise value

$460.45M
ANAB enterprise value is $460.45 million

Enterprise value Sector rank

68.9%
ANAB enterprise value is higher than 68.9% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.96
ANAB EV/EBITDA is -4.96

EV/EBITDA Sector rank

18.62%
ANAB EV/EBITDA is higher than 18.62% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

9.51
ANAB annual current ratio is 9.51

Quick ratio

-
ANAB annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ANAB annual debt to equity ratio is 0.00

Interest coverage ratio

-1.90
ANAB annual interest coverage ratio is -1.90

Risk & Stability

Piotroski F-Score

-
ANAB piotroski f-score value is unknown

Altman Z-Score

-0.87
ANAB altman z-score is -0.87

Analyst ratings

Recent major analysts updates

Mar 5, 25 JP Morgan
Overweight
Mar 4, 25 HC Wainwright & Co.
Neutral
Feb 13, 25 Wells Fargo
Overweight
Feb 7, 25 Wedbush
Outperform
Feb 4, 25 Wolfe Research
Outperform
Feb 4, 25 HC Wainwright & Co.
Neutral
Dec 19, 24 JP Morgan
Overweight
Dec 18, 24 Truist Securities
Hold
Dec 12, 24 Wells Fargo
Overweight
Dec 12, 24 Guggenheim
Buy

Institutional Ownership

Similar stocks

COGT logo
Cogent Biosciences (COGT)
SIBN logo
SI-BONE (SIBN)
AVNS logo
Avanos Medical (AVNS)
GHRS logo
GH Research (GHRS)
PHAR logo
Pharming Group NV (PHAR)
ORGO logo
Organogenesis Holdings (ORGO)
BCYC logo
Bicycle Therapeutics (BCYC)
VALN logo
Valneva SE (VALN)
ACCD logo
Accolade (ACCD)
  • What is the ticker symbol for AnaptysBio?
  • Does AnaptysBio pay dividends?
  • What sector is AnaptysBio in?
  • What industry is AnaptysBio in?
  • What country is AnaptysBio based in?
  • When did AnaptysBio go public?
  • Is AnaptysBio in the S&P 500?
  • Is AnaptysBio in the NASDAQ 100?
  • Is AnaptysBio in the Dow Jones?
  • When was AnaptysBio's last earnings report?
  • When does AnaptysBio report earnings?
  • Should I buy AnaptysBio stock now?

What is the ticker symbol for AnaptysBio?

The ticker symbol for AnaptysBio is NASDAQ:ANAB

Does AnaptysBio pay dividends?

No, AnaptysBio does not pay dividends

What sector is AnaptysBio in?

AnaptysBio is in the Healthcare sector

What industry is AnaptysBio in?

AnaptysBio is in the Biotechnology industry

What country is AnaptysBio based in?

AnaptysBio is headquartered in United States

When did AnaptysBio go public?

AnaptysBio's initial public offering (IPO) was on January 26, 2017

Is AnaptysBio in the S&P 500?

No, AnaptysBio is not included in the S&P 500 index

Is AnaptysBio in the NASDAQ 100?

No, AnaptysBio is not included in the NASDAQ 100 index

Is AnaptysBio in the Dow Jones?

No, AnaptysBio is not included in the Dow Jones index

When was AnaptysBio's last earnings report?

AnaptysBio's most recent earnings report was on Feb 27, 2025

When does AnaptysBio report earnings?

The next expected earnings date for AnaptysBio is May 9, 2025

Should I buy AnaptysBio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page